(Q34648838)

3 August 2017

Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patient (English)

1 reference

Jennifer McKimm-Breschkin

3 August 2017

1 reference

Jennifer L McKimm-Breschkin

7

0 references

Aeron C. Hurt

Aeron C Hurt

1

0 references

Ian G. Barr

Ian G Barr

6

0 references

Naomi Komadina

4

Naomi Komadina

1 reference

3 August 2017

5

Alan W Hampson

1 reference

3 August 2017

Pina Iannello

2

1 reference

PubMed ID

16641465

3 August 2017

Kim Jachno

3

1 reference

PubMed ID

16641465

3 August 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

Antimicrobial Agents and Chemotherapy

3 August 2017

1 reference

3 August 2017

50

1 reference

3 August 2017

5

1 reference

3 August 2017

1872-1874

1 reference

Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472236

The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472236

Treatment of influenza with neuraminidase inhibitors: virological implications

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472236

Oral oseltamivir treatment of influenza in children.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472236

Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472236

Resistance of influenza viruses to neuraminidase inhibitors--a review.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472236

Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472236

Influenza virus neuraminidase: structure, antibodies, and inhibitors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472236

The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472236

The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472236

Resistant influenza A viruses in children treated with oseltamivir: descriptive study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472236

Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugs

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472236

Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472236

Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472236

10.1128/AAC.50.5.1872-1874.2006

26 October 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

PubMed ID

16641465